Loading
Senior medical oncologist and translational researcher who leads research at NCIS, with a long record in experimental therapeutics and head and neck cancer.
Goh Boon Cher is Deputy Director (Research) at the National University Cancer Institute, Singapore, and a professor at the National University of Singapore. His work centres on early-phase clinical trials, pharmacology of anticancer drugs and head and neck/nasopharyngeal cancers, and he has led many investigator-initiated trials in Asia.
| Title | Journal | Year |
|---|---|---|
| Phase II study of TAS‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer | Cancer Medicine | 2013 |
| Different treatment efficacies and side effects of cytotoxic chemotherapy | Journal of Thoracic Disease | 2020 |
Shares Nasopharyngeal carcinoma, Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist, head and neck cancer.
Shares National University Hospital / National University Cancer Institute, Singapore and the tags leadership, clinician-scientist.
Shares National University Hospital / National University Cancer Institute, Singapore and the tags leadership, clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist, head and neck cancer.
Shares Cancer medicine and the tags leadership, clinician-scientist.
Shares Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist, head and neck cancer.
Shares Head and neck squamous cell carcinoma and the tags leadership, clinician-scientist, head and neck cancer.
Shares Cancer medicine and the tags leadership, clinician-scientist.